Drug Trial Radar · NCT04546399
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
461
Planned (sponsor's estimate)
Start
Dec 17, 2020
Primary completion
Jun 30, 2028
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Sep 14, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein that identifies and targets specific molecules in the body. Blinatumomab searches for and attaches itself to the cancer cell. Once attached, an immune response occurs which may kill the cancer cell. Nivolumab is a medicine that may boost a patient's immune system. Giving nivolumab in combination with blinatumomab may cause the cancer to stop growing for a period of time, and for some patients, it may lessen the symptoms, such as pain, that are caused by the cancer.
Conditions
- Down Syndrome
- Recurrent B Acute Lymphoblastic Leukemia
Interventions
3-Dimensional Conformal Radiation TherapyRadiation
Undergo 3D-CRT
Asparaginase Erwinia chrysanthemiDrug
Given IM
Biospecimen CollectionProcedure
Undergo blood, urine and cerebrospinal fluid collection
BlinatumomabBiological
Given IV
Bone Marrow AspirationProcedure
Undergo bone marrow aspiration
Bone Marrow BiopsyProcedure
Undergo bone marrow biopsy
Calaspargase PegolDrug
Given IV
CytarabineDrug
Given IT
DexamethasoneDrug
Given PO or IV
Hydrocortisone Sodium SuccinateDrug
Given IT
Lumbar PunctureProcedure
Undergo lumbar puncture
MercaptopurineDrug
Given PO
MethotrexateDrug
Given IT, PO, and IV
NivolumabBiological
Given IV
PegaspargaseDrug
Given IM or IV
Vincristine SulfateDrug
Given IV push or via infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Minimal residual disease (MRD) negative second remission (Rem-2) rate with blinatumomab vs with blinatumomab + nivolumab (Group 1)Time frame: Up to 2 cycles of therapy (each cycle = 36 days)
- Event-free survival post-reinduction (EFS PR) (Group 3)Time frame: From date of randomization to date of treatment failure, relapse, second malignancy (SMN) or death due to any cause, assessed up to 10 years after completion of enrollment.
- EFS PR (Group 4)Time frame: From date of randomization to date of treatment failure, relapse, second malignancy (SMN) or death due to any cause, assessed up to 10 years after completion of enrollment.
Locations
229 sites in 4 countries. Site status is shown where the registry gives one.
Children's Hospital of Alabama
Birmingham, Alabama · Recruiting
USA Health Strada Patient Care Center
Mobile, Alabama · Recruiting
Providence Alaska Medical Center
Anchorage, Alaska · Recruiting
Kingman Regional Medical Center
Kingman, Arizona · Suspended
Banner Children's at Desert
Mesa, Arizona · Recruiting
Phoenix Childrens Hospital
Phoenix, Arizona · Recruiting
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
Arkansas Children's Hospital
Little Rock, Arkansas · Recruiting
Kaiser Permanente-Anaheim
Anaheim, California · Suspended
PCR Oncology
Arroyo Grande, California · Suspended
Kaiser Permanente-Bellflower
Bellflower, California · Suspended
Kaiser Permanente Downey Medical Center
Downey, California · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Active not recruiting
Kaiser Permanente-Fontana
Fontana, California · Recruiting
Loma Linda University Medical Center
Loma Linda, California · Recruiting
Miller Children's and Women's Hospital Long Beach
Long Beach, California · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California · Suspended
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
Mattel Children's Hospital UCLA
Los Angeles, California · Recruiting
Valley Children's Hospital
Madera, California · Recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Children's Hospital of Orange County
Orange, California · Recruiting
Lucile Packard Children's Hospital Stanford University
Palo Alto, California · Recruiting
Sutter Medical Center Sacramento
Sacramento, California · Recruiting
University of California Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
Kaiser Permanente-San Diego Zion
San Diego, California · Recruiting
Rady Children's Hospital - San Diego
San Diego, California · Recruiting
UCSF Medical Center-Mission Bay
San Francisco, California · Recruiting
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California · Active not recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Denver, Colorado · Recruiting
Connecticut Children's Medical Center
Hartford, Connecticut · Recruiting
Alfred I duPont Hospital for Children
Wilmington, Delaware · Recruiting
MedStar Georgetown University Hospital
Washington D.C., District of Columbia · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida · Recruiting
UF Health Cancer Institute - Gainesville
Gainesville, Florida · Recruiting
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida · Recruiting
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida · Recruiting
Showing 40 of 229 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.